SEC Form 4/A · accession 0001232524-16-000358
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Bruce C Cozadd
Officer — Chairman & CEO · Director
Period of report
Aug 9, 2016
Accepted (ET)
Aug 17, 2016 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | holding | — | — | — | 290,113 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Form 4 that was filed on August 11, 2016 correctly stated the Reporting Person's transactions and end-of-period holdings and is being amended solely to attach the Power of Attorney.